Breaking News Instant updates and real-time market news.

CCJ

Cameco

$17.22 /

-0.425 (-2.41%)

17:01
04/09/21
04/09
17:01
04/09/21
17:01

Cameco restarting Cigar Lake mine in April

Cameco announced that it plans to restart production in April at its Cigar Lake uranium mine located in northern Saskatchewan. Production at Cigar Lake was temporarily suspended in December 2020 due to increasing risks posed by the Coronavirus (COVID-19) pandemic. At that time, the availability of workers in critical areas was shrinking due to the pandemic, with more individuals screening out or residing in communities with pandemic-related travel restrictions. "The safety of our workers, their families and communities is always our top priority," said Cameco president and CEO Tim Gitzel. "In recent months we have implemented several enhanced safety protocols for Cigar Lake, including increased distancing between passengers on flights, mandatory medical-grade masks for all workers and increased sanitization and physical barriers in our eating areas. We also worked with the Saskatchewan Health Authority and have established a licensed COVID-19 testing facility at the mine site. These further safety measures, along with the provincial vaccine rollout program and increased confidence around our ability to manage our critical workforce, have given us greater certainty that Cigar Lake will be able to operate safely and sustainably." As the restart process begins, Cameco will closely monitor the COVID-19 case counts and the ongoing success of the vaccine rollout, and will continue to have regular dialogue with public health authorities and northern Saskatchewan leaders.

  • 07

    May

CCJ Cameco
$17.22 /

-0.425 (-2.41%)

02/12/21 BMO Capital
Cameco price target raised to C$23 from C$18.50 at BMO Capital
02/11/21 Scotiabank
Cameco price target raised to C$23 from C$22 at Scotiabank
02/11/21 TD Securities
Cameco price target raised to C$20 from C$18 at TD Securities
02/11/21 BofA
Cameco downgraded to Neutral from Buy at BofA

TODAY'S FREE FLY STORIES

Recommendations
Booking Holdings price target lowered to $2,675 from $2,740 at Credit Suisse » 08:14
05/06/21
05/06
08:14
05/06/21
08:14
BKNG

Booking Holdings

$2,333.00 /

-53.02 (-2.22%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKNG Booking Holdings
$2,333.00 /

-53.02 (-2.22%)

BKNG Booking Holdings
$2,333.00 /

-53.02 (-2.22%)

07:30 Today Deutsche Bank
Booking Holdings price target raised to $2,665 from $2,600 at Deutsche Bank
06:42 Today Barclays
Booking Holdings price target raised to $2,740 from $2,710 at Barclays
04/27/21 BTIG
Booking Holdings off to slow start, says BTIG
04/22/21 Cowen
Booking Holdings price target raised to $2700 from $2550 at Cowen
BKNG Booking Holdings
$2,333.00 /

-53.02 (-2.22%)

BKNG Booking Holdings
$2,333.00 /

-53.02 (-2.22%)

BKNG Booking Holdings
$2,333.00 /

-53.02 (-2.22%)

Recommendations
Cedar Fair price target raised to $75 from $70 at B. Riley » 08:14
05/06/21
05/06
08:14
05/06/21
08:14
FUN

Cedar Fair

$48.51 /

-0.92 (-1.86%)

B. Riley analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FUN Cedar Fair
$48.51 /

-0.92 (-1.86%)

FUN Cedar Fair
$48.51 /

-0.92 (-1.86%)

03/24/21 Stifel
Cedar Fair price target raised to $58 from $56 at Stifel
03/12/21 Wedbush
Cedar Fair price target raised to $61 from $54 at Wedbush
03/08/21 B. Riley Securities
Cedar Fair price target raised to $70 from $57 at B. Riley Securities
02/19/21 Credit Suisse
Cedar Fair price target raised to $65 from $42 at Credit Suisse
FUN Cedar Fair
$48.51 /

-0.92 (-1.86%)

FUN Cedar Fair
$48.51 /

-0.92 (-1.86%)

Hot Stocks
DarwinHealth announces research collaboration with Bristol Myers » 08:14
05/06/21
05/06
08:14
05/06/21
08:14
BMY

Bristol-Myers

$64.67 /

+0.68 (+1.06%)

DarwinHealth, a New York…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$64.67 /

+0.68 (+1.06%)

BMY Bristol-Myers
$64.67 /

+0.68 (+1.06%)

05/05/21 Wells Fargo
Wells sees 'limited impact' on Iovance's lifileucel from Keytruda/Yervoy data
04/30/21
Fly Intel: Top five analyst downgrades
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight on pipeline questions at Morgan Stanley
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight from Overweight at Morgan Stanley
BMY Bristol-Myers
$64.67 /

+0.68 (+1.06%)

BMY Bristol-Myers
$64.67 /

+0.68 (+1.06%)

BMY Bristol-Myers
$64.67 /

+0.68 (+1.06%)

BMY Bristol-Myers
$64.67 /

+0.68 (+1.06%)

Hot Stocks
FDA approves Orgenesis IDE for pilot clinical trial of Tissue Genesis Icellator2 » 08:14
05/06/21
05/06
08:14
05/06/21
08:14
ORGS

Orgenesis

$4.47 /

-0.09 (-1.97%)

Orgenesis announces it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORGS Orgenesis
$4.47 /

-0.09 (-1.97%)

ORGS Orgenesis
$4.47 /

-0.09 (-1.97%)

ORGS Orgenesis
$4.47 /

-0.09 (-1.97%)

Earnings
Shyft Group backs FY21 adjusted EPS view $1.65-$1.85, consensus $1.78 » 08:13
05/06/21
05/06
08:13
05/06/21
08:13
SHYF

Shyft Group

$33.85 /

-0.45 (-1.31%)

Backs FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHYF Shyft Group
$33.85 /

-0.45 (-1.31%)

SHYF Shyft Group
$33.85 /

-0.45 (-1.31%)

01/04/21 Colliers
Shyft Group price target raised to $35 from $25 at Colliers
12/17/20 Raymond James
Shyft Group initiated with an Outperform at Raymond James
12/16/20 Raymond James
Shyft Group initiated with an Outperform at Raymond James
11/05/20 Craig-Hallum
Shyft Group target raised to $26 after 'blowout Q3' at Craig-Hallum
SHYF Shyft Group
$33.85 /

-0.45 (-1.31%)

Hot Stocks
Tapestry expects to exceed 2019 operating income, EPS for FY21 » 08:13
05/06/21
05/06
08:13
05/06/21
08:13
TPR

Tapestry

$48.40 /

+0.405 (+0.84%)

Comments taken from Q3…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TPR Tapestry
$48.40 /

+0.405 (+0.84%)

TPR Tapestry
$48.40 /

+0.405 (+0.84%)

05/03/21 Deutsche Bank
Tapestry price target raised to $54 from $45 at Deutsche Bank
04/15/21 OTR Global
Tapestry upgraded to Positive from Mixed at OTR Global
04/07/21 Piper Sandler
Tapestry price target raised to $54 from $45 at Piper Sandler
03/05/21 BMO Capital
Tapestry price target raised to $45 from $36 at BMO Capital
TPR Tapestry
$48.40 /

+0.405 (+0.84%)

TPR Tapestry
$48.40 /

+0.405 (+0.84%)

TPR Tapestry
$48.40 /

+0.405 (+0.84%)

Upgrade
Ultragenyx upgraded to Outperform from In Line at Evercore ISI » 08:13
05/06/21
05/06
08:13
05/06/21
08:13
RARE

Ultragenyx

$106.22 /

+4.49 (+4.41%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RARE Ultragenyx
$106.22 /

+4.49 (+4.41%)

RARE Ultragenyx
$106.22 /

+4.49 (+4.41%)

05:58 Today Citi
Ultragenyx upgraded to Buy from Neutral at Citi
05/05/21 Evercore ISI
Evercore upgrades Ultragenyx with 'good handle' on Angelman program
05/05/21 Evercore ISI
Ultragenyx upgraded to Outperform from In Line at Evercore ISI
04/26/21 Credit Suisse
Ultragenyx assumed with a Neutral at Credit Suisse
RARE Ultragenyx
$106.22 /

+4.49 (+4.41%)

  • 29
    Oct
Hot Stocks
Biofrontera reports April revenue EUR 6.6M vs. EUR 6M last year » 08:12
05/06/21
05/06
08:12
05/06/21
08:12
BFRA

Biofrontera

$5.25 /

+0.025 (+0.48%)

The Company's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BFRA Biofrontera
$5.25 /

+0.025 (+0.48%)

BFRA Biofrontera
$5.25 /

+0.025 (+0.48%)

05/20/20 Lake Street
Biofrontera upgraded to Buy from Hold at Lake Street
BFRA Biofrontera
$5.25 /

+0.025 (+0.48%)

  • 24
    Feb
Earnings
Bicycle Therapeutics reports Q1 EPS (73c), consensus (71c) » 08:12
05/06/21
05/06
08:12
05/06/21
08:12
BCYC

Bicycle Therapeutics

$31.05 /

-0.21 (-0.67%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCYC Bicycle Therapeutics
$31.05 /

-0.21 (-0.67%)

BCYC Bicycle Therapeutics
$31.05 /

-0.21 (-0.67%)

04/20/21 JMP Securities
Bicycle Therapeutics initiated with an Outperform at JMP Securities
01/20/21 Cantor Fitzgerald
Bicycle Therapeutics price target raised to $58 from $30 at Cantor Fitzgerald
01/15/21 Oppenheimer
Bicycle Therapeutics price target raised to $38 from $27 at Oppenheimer
01/15/21 H.C. Wainwright
Bicycle Therapeutics price target raised to $31 from $28 at H.C. Wainwright
BCYC Bicycle Therapeutics
$31.05 /

-0.21 (-0.67%)

Recommendations
MercadoLibre price target lowered to $1,824 from $1,850 at Credit Suisse » 08:12
05/06/21
05/06
08:12
05/06/21
08:12
MELI

MercadoLibre

$1,523.49 /

+0.81 (+0.05%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MELI MercadoLibre
$1,523.49 /

+0.81 (+0.05%)

MELI MercadoLibre
$1,523.49 /

+0.81 (+0.05%)

05:26 Today Stifel
MercadoLibre upgraded to Buy from Hold at Stifel
05/03/21 Credit Suisse
MercadoLibre price target lowered to $1,850 from $1,925 at Credit Suisse
03/31/21 Wolfe Research
MercadoLibre initiated with an Outperform at Wolfe Research
03/11/21 BTIG
MercadoLibre upgraded to Buy from Neutral at BTIG
MELI MercadoLibre
$1,523.49 /

+0.81 (+0.05%)

MELI MercadoLibre
$1,523.49 /

+0.81 (+0.05%)

Earnings
Nova Measuring sees Q2 adjusted EPS 64c-77c, consensus 64c » 08:12
05/06/21
05/06
08:12
05/06/21
08:12
NVMI

Nova Measuring

$89.98 /

+0.57 (+0.64%)

Sees Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVMI Nova Measuring
$89.98 /

+0.57 (+0.64%)

NVMI Nova Measuring
$89.98 /

+0.57 (+0.64%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Stifel
Nova Measuring upgraded to Buy ahead of earnings at Stifel
05/05/21 Stifel
Nova Measuring upgraded to Buy from Hold at Stifel
05/04/21 Stifel
Intel spending plans show new CEO 'gets it,' says Stifel
NVMI Nova Measuring
$89.98 /

+0.57 (+0.64%)

Earnings
Arrow Electronics reports Q1 EPS $2.84, consensus $2.30 » 08:12
05/06/21
05/06
08:12
05/06/21
08:12
ARW

Arrow Electronics

$112.63 /

+0.92 (+0.82%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARW Arrow Electronics
$112.63 /

+0.92 (+0.82%)

ARW Arrow Electronics
$112.63 /

+0.92 (+0.82%)

02/23/21 Citi
Citi opens long Arrow Electronics, short Avnet pair trade
02/05/21 Citi
Arrow Electronics price target raised to $110 from $85 at Citi
12/14/20 Goldman Sachs
Arrow Electronics price target raised to $96 from $81 at Goldman Sachs
10/30/20 Citi
Arrow Electronics price target raised to $85 from $75 at Citi
ARW Arrow Electronics
$112.63 /

+0.92 (+0.82%)

ARW Arrow Electronics
$112.63 /

+0.92 (+0.82%)

Recommendations
Hub Group price target raised to $72 from $58 at BMO Capital » 08:12
05/06/21
05/06
08:12
05/06/21
08:12
HUBG

Hub Group

$70.18 /

+1.63 (+2.38%)

BMO Capital analyst Fadi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUBG Hub Group
$70.18 /

+1.63 (+2.38%)

HUBG Hub Group
$70.18 /

+1.63 (+2.38%)

07:19 Today Susquehanna
Hub Group price target raised to $83 from $79 at Susquehanna
03/08/21 Wells Fargo
Hub Group price target raised to $81 from $65 at Wells Fargo
02/19/21 UBS
Hub Group upgraded to Buy from Neutral at UBS
02/19/21 UBS
Hub Group upgraded to Buy from Neutral at UBS
HUBG Hub Group
$70.18 /

+1.63 (+2.38%)

Earnings
Shyft Group reports Q1 adjusted EPS 36c, consensus 33c » 08:12
05/06/21
05/06
08:12
05/06/21
08:12
SHYF

Shyft Group

$33.85 /

-0.45 (-1.31%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHYF Shyft Group
$33.85 /

-0.45 (-1.31%)

SHYF Shyft Group
$33.85 /

-0.45 (-1.31%)

01/04/21 Colliers
Shyft Group price target raised to $35 from $25 at Colliers
12/17/20 Raymond James
Shyft Group initiated with an Outperform at Raymond James
12/16/20 Raymond James
Shyft Group initiated with an Outperform at Raymond James
11/05/20 Craig-Hallum
Shyft Group target raised to $26 after 'blowout Q3' at Craig-Hallum
SHYF Shyft Group
$33.85 /

-0.45 (-1.31%)

Hot Stocks
Trevena announces TRV027 selected by ACTIV initiative for COVID-19 trial » 08:11
05/06/21
05/06
08:11
05/06/21
08:11
TRVN

Trevena

$1.77 /

+0.08 (+4.75%)

Trevena announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRVN Trevena
$1.77 /

+0.08 (+4.75%)

TRVN Trevena
$1.77 /

+0.08 (+4.75%)

03/15/21 Oppenheimer
Trevena initiated with a Perform at Oppenheimer
09/14/20 Guggenheim
Guggenheim starts Trevena at Buy ahead of launch of Olinvyk
09/14/20 Guggenheim
Trevena initiated with a Buy at Guggenheim
08/28/20
Fly Intel: Top five analyst initiations
TRVN Trevena
$1.77 /

+0.08 (+4.75%)

  • 12
    Aug
TRVN Trevena
$1.77 /

+0.08 (+4.75%)

Earnings
Nova Measuring reports Q1 adjusted EPS 70c, consensus 62c » 08:11
05/06/21
05/06
08:11
05/06/21
08:11
NVMI

Nova Measuring

$89.98 /

+0.57 (+0.64%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVMI Nova Measuring
$89.98 /

+0.57 (+0.64%)

NVMI Nova Measuring
$89.98 /

+0.57 (+0.64%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Stifel
Nova Measuring upgraded to Buy ahead of earnings at Stifel
05/05/21 Stifel
Nova Measuring upgraded to Buy from Hold at Stifel
05/04/21 Stifel
Intel spending plans show new CEO 'gets it,' says Stifel
NVMI Nova Measuring
$89.98 /

+0.57 (+0.64%)

Hot Stocks
Antares Pharma appoints Joseph Renda as SVP, commercial » 08:11
05/06/21
05/06
08:11
05/06/21
08:11
ATRS

Antares Pharma

$3.78 /

+0.04 (+1.07%)

Antares Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATRS Antares Pharma
$3.78 /

+0.04 (+1.07%)

ATRS Antares Pharma
$3.78 /

+0.04 (+1.07%)

Earnings
Starwood Property reports Q1 distributable EPS 50c, consensus 49c » 08:10
05/06/21
05/06
08:10
05/06/21
08:10
STWD

Starwood Property

$25.35 /

-0.08 (-0.31%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STWD Starwood Property
$25.35 /

-0.08 (-0.31%)

04/26/21 JPMorgan
Starwood Property price target raised to $25 from $22 at JPMorgan
02/26/21 JPMorgan
Starwood Property price target raised to $22 from $21 at JPMorgan
02/26/21 JPMorgan
Starwood Property price target raised to $22 from $21 at JPMorgan
02/02/21 BTIG
Starwood Property initiated with a Buy at BTIG
STWD Starwood Property
$25.35 /

-0.08 (-0.31%)

Earnings
Amyris sees FY21 revenue $400M, consensus $337.46M » 08:10
05/06/21
05/06
08:10
05/06/21
08:10
AMRS

Amyris

$13.61 /

-0.95 (-6.52%)

For FY21: Underlying…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMRS Amyris
$13.61 /

-0.95 (-6.52%)

AMRS Amyris
$13.61 /

-0.95 (-6.52%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$13.61 /

-0.95 (-6.52%)

  • 09
    Apr
AMRS Amyris
$13.61 /

-0.95 (-6.52%)

AMRS Amyris
$13.61 /

-0.95 (-6.52%)

Recommendations
PayPal price target raised to $315 from $310 at Credit Suisse » 08:10
05/06/21
05/06
08:10
05/06/21
08:10
PYPL

PayPal

$247.60 /

-2.63 (-1.05%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PYPL PayPal
$247.60 /

-2.63 (-1.05%)

PYPL PayPal
$247.60 /

-2.63 (-1.05%)

08:04 Today Morgan Stanley
PayPal price target raised to $337 from $329 at Morgan Stanley
07:36 Today Wells Fargo
PayPal price target raised to $310 from $280 at Wells Fargo
06:17 Today JMP Securities
PayPal price target raised to $300 from $275 at JMP Securities
04/21/21 Mizuho
Mizuho starts Coinbase with a Neutral, sees risk of margin squeeze
PYPL PayPal
$247.60 /

-2.63 (-1.05%)

PYPL PayPal
$247.60 /

-2.63 (-1.05%)

PYPL PayPal
$247.60 /

-2.63 (-1.05%)

PYPL PayPal
$247.60 /

-2.63 (-1.05%)

Recommendations
SiteOne Landscape price target raised to $159 from $138 at RBC Capital » 08:09
05/06/21
05/06
08:09
05/06/21
08:09
SITE

SiteOne Landscape

$193.09 /

+8.1 (+4.38%)

RBC Capital analyst Mike…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SITE SiteOne Landscape
$193.09 /

+8.1 (+4.38%)

SITE SiteOne Landscape
$193.09 /

+8.1 (+4.38%)

06:50 Today Baird
SiteOne Landscape price target raised to $200 from $185 at Baird
06:48 Today Barclays
SiteOne Landscape price target raised to $199 from $163 at Barclays
04/15/21 UBS
SiteOne Landscape price target raised to $132 from $127 at UBS
02/25/21 Truist
SiteOne Landscape price target raised to $186 from $130 at Truist
SITE SiteOne Landscape
$193.09 /

+8.1 (+4.38%)

  • 04
    Aug
Earnings
Amyris reports Q1 adjusted EPS 35c, consensus (2c) » 08:09
05/06/21
05/06
08:09
05/06/21
08:09
AMRS

Amyris

$13.61 /

-0.95 (-6.52%)

Reports Q1 revenue $177M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMRS Amyris
$13.61 /

-0.95 (-6.52%)

AMRS Amyris
$13.61 /

-0.95 (-6.52%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$13.61 /

-0.95 (-6.52%)

  • 09
    Apr
AMRS Amyris
$13.61 /

-0.95 (-6.52%)

AMRS Amyris
$13.61 /

-0.95 (-6.52%)

Hot Stocks
Applied Genetic reports data from the ongoing XLRP phase 1/2 clinical trial » 08:09
05/06/21
05/06
08:09
05/06/21
08:09
AGTC

Applied Genetic

$3.85 /

-0.045 (-1.16%)

Applied Genetic reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGTC Applied Genetic
$3.85 /

-0.045 (-1.16%)

AGTC Applied Genetic
$3.85 /

-0.045 (-1.16%)

04/19/21 Roth Capital
Roth Capital 'bullish' on Applied Genetic's technology, pipeline outlook
04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
AGTC Applied Genetic
$3.85 /

-0.045 (-1.16%)

  • 28
    Jan
AGTC Applied Genetic
$3.85 /

-0.045 (-1.16%)

Recommendations
CyberArk price target lowered to $165 from $180 at Monness Crespi » 08:08
05/06/21
05/06
08:08
05/06/21
08:08
CYBR

CyberArk

$119.22 /

-15.56 (-11.54%)

Monness Crespi analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYBR CyberArk
$119.22 /

-15.56 (-11.54%)

CYBR CyberArk
$119.22 /

-15.56 (-11.54%)

06:55 Today Baird
CyberArk price target lowered to $160 from $170 at Baird
04/08/21 Morgan Stanley
Okta announcements validate CyberArk, SailPoint opportunity, says Morgan Stanley
04/07/21 Baird
Baird upgrades CyberArk to Outperform on SaaS model transition
04/07/21 Baird
CyberArk upgraded to Outperform from Neutral at Baird
CYBR CyberArk
$119.22 /

-15.56 (-11.54%)

CYBR CyberArk
$119.22 /

-15.56 (-11.54%)

Hot Stocks
Amicus appoints Sebastien Martel as SVP, strategy and business development » 08:08
05/06/21
05/06
08:08
05/06/21
08:08
FOLD

Amicus

$9.58 /

-0.13 (-1.34%)

, SNY

Sanofi

$50.56 /

+0.12 (+0.24%)

Amicus Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$9.58 /

-0.13 (-1.34%)

SNY Sanofi
$50.56 /

+0.12 (+0.24%)

FOLD Amicus
$9.58 /

-0.13 (-1.34%)

04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
04/14/21 Cantor Fitzgerald
Amicus upgraded to Overweight from Neutral at Cantor Fitzgerald
04/13/21 Cantor Fitzgerald
Amicus upgraded to Overweight from Neutral at Cantor Fitzgerald
03/01/21 Stifel
Amicus initiated with a Hold at Stifel
SNY Sanofi
$50.56 /

+0.12 (+0.24%)

04/30/21 Deutsche Bank
Sanofi price target raised to EUR 75 from EUR 70 at Deutsche Bank
04/29/21 Barclays
Sanofi price target raised to EUR 90 from EUR 85 at Barclays
04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
FOLD Amicus
$9.58 /

-0.13 (-1.34%)

SNY Sanofi
$50.56 /

+0.12 (+0.24%)

FOLD Amicus
$9.58 /

-0.13 (-1.34%)

SNY Sanofi
$50.56 /

+0.12 (+0.24%)

FOLD Amicus
$9.58 /

-0.13 (-1.34%)

SNY Sanofi
$50.56 /

+0.12 (+0.24%)

FOLD Amicus
$9.58 /

-0.13 (-1.34%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.